Glia,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 25, 2024
Abstract
Substantial
advances
in
technology
are
permitting
a
high
resolution
understanding
of
the
salience
glia,
and
have
helped
us
to
transcend
decades
predominantly
neuron‐centric
research.
In
particular,
recent
‘omic’
technologies
enabled
unique
insights
into
glial
biology,
shedding
light
on
cellular
molecular
aspects
neurodegenerative
diseases,
including
amyotrophic
lateral
sclerosis
(ALS).
Here,
we
review
studies
using
omic
techniques
attempt
understand
role
glia
ALS
across
different
model
systems
post
mortem
tissue.
We
also
address
caveats
that
should
be
considered
when
interpreting
such
studies,
how
some
these
may
mitigated
through
either
multi‐omic
approach
and/or
careful
low
throughput,
fidelity
orthogonal
validation
with
particular
emphasis
functional
validation.
Finally,
consider
emerging
their
potential
relevance
deepening
our
ALS.
Neurobiology of Disease,
Journal Year:
2024,
Volume and Issue:
unknown, P. 106759 - 106759
Published: Dec. 1, 2024
Mutations
in
the
microtubule-binding
motor
protein
kinesin
5
A
(KIF5A)
are
impacted
several
adult-onset
neuron
diseases,
including
Amyotrophic
Lateral
Sclerosis,
Spastic
Paraplegia
Type
10
and
Charcot-Marie-Tooth
Disease
2.
While
KIF5
family
members
transport
a
variety
of
cargos
along
axons,
specific
affected
by
KIF5A
mutations
remain
poorly
understood.
Here,
we
generated
null
mutant
human
neurons
analyzed
impact
on
axonal
outgrowth
regeneration
vitro.
deficiency
caused
reduced
neurite
complexity
young
(DIV14)
defects
regeneration.
did
not
affect
neurofilament
but
impaired
mitochondrial
motility
anterograde
speed
at
DIV42.
Notably,
strongly
splicing
factor
proline/glutamine-rich
(SFPQ)-associated
RNA
granules
DIV42
axons.
Hence,
plays
critical
role
promoting
regrowth
after
injury
driving
mitochondria
especially
SFPQ-associated
mature
neurons.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 20, 2024
Abstract
Amyotrophic
Lateral
Sclerosis
(ALS)
is
a
complex
syndrome
with
multiple
genetic
causes
and
wide
variation
in
disease
presentation.
Despite
this
general
heterogeneity,
several
common
factors
have
been
identified.
For
example,
nearly
all
patients
show
pathological
accumulations
of
phosphorylated
TDP-43
protein
affected
regions
the
motor
cortex
spinal
cord.
Moreover,
large
patient
cohort
studies
revealed
that
most
samples
can
be
grouped
into
small
number
ALS
subtypes,
as
defined
by
their
transcriptomic
profiles.
These
molecular
subtypes
whether
postmortem
display
signatures
of:
mitochondrial
dysfunction
oxidative
stress
(ALS-Ox),
microglial
activation
neuroinflammation
(ALS-Glia),
or
dense
pathology
associated
transposable
element
de-silencing
(ALS-TE).
In
study,
we
built
deep
layer
neural
network
classifier
(DANcer)
has
learned
to
accurately
assign
these
which
run
on
either
bulk
single-cell
datasets.
Upon
applying
an
expanded
from
NYGC
Consortium,
Molecular
Subtypes
are
robust
across
clinical
centers,
no
new
appearing
quadrupled
size.
Signatures
two
strongly
correlate
duration:
ALS-TE
ALS-Glia
cord,
revealing
correlates
features.
Finally,
use
single
nucleus
RNA
sequencing
reveal
cell
type-specific
contributions
subtype,
determined
our
(scDANCer).
Single-cell
transcriptomes
recapitulated
neurons
glia,
both
ALS-wide
shared
alterations
each
type
well
subtype-specific
alterations.
summary,
subtypes:
(1)
cohorts
sporadic
familial
samples,
(2)
represent
combination
cellular,
genetic,
features,
(3)
features
ALS.
Figure
0:
Graphical
-
multiomics
classifiers.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 1, 2024
One
of
the
unifying
pathological
hallmarks
Parkinson's
disease
(PD)
and
dementia
with
Lewy
bodies
(DLB)
is
presence
misfolded,
aggregated,
often
phosphorylated
forms
protein
α-synuclein
in
neurons.
α-Synuclein
pathology
appears
select
populations
neurons
throughout
various
cortical
subcortical
regions,
little
currently
known
about
why
some
develop
while
others
are
spared.
Here,
we
utilized
subcellular-resolution
imaging-based
spatial
transcriptomics
(IST)
a
transgenic
mouse
model
that
overexpresses
wild-type
human
(α-syn-tg)
to
evaluate
patterns
selective
neuronal
vulnerability
pathology.
By
performing
post-IST
immunofluorescence
for
at
Ser129
(pSyn),
identified
cell
types
cortex
hippocampus
were
vulnerable
or
resistant
developing
pSyn
Next,
investigated
transcriptional
underpinnings
observed
using
set
custom
probes
detect
genes
involved
processing
toxicity.
We
expression
kinase:substrate
pair
Plk2
,
which
phosphorylates
Ser129,
SNCA
(
hSNCA
),
as
underlying
Finally,
performed
differential
gene
analysis,
comparing
non-transgenic
cells
pSyn-
pSyn+
α-syn-
tg
reveal
changes
downstream
overexpression
pathology,
included
pSyn-dependent
alterations
mitochondrial
endolysosomal
genes.
This
study
provides
comprehensive
use
case
IST,
yielding
new
biological
insights
into
formation
its
effects
PD/DLB
model.
Acta Neuropathologica Communications,
Journal Year:
2024,
Volume and Issue:
12(1)
Published: Sept. 18, 2024
A
hexanucleotide
repeat
expansion
(HRE)
in
C9ORF72
is
the
most
common
genetic
cause
of
amyotrophic
lateral
sclerosis
(ALS)
and
frontotemporal
dementia
(FTD).
Human
brain
imaging
experimental
studies
indicate
early
changes
structure
connectivity
C9-ALS/FTD,
even
before
symptom
onset.
Because
these
disease
phenotypes
remain
incompletely
understood,
we
generated
iPSC-derived
cerebral
organoid
models
from
C9-ALS/FTD
patients,
presymptomatic
C9ORF72-HRE
(C9-HRE)
carriers,
controls.
Our
work
revealed
presence
all
three
C9-HRE-related
molecular
pathologies
developmental
stage-dependent
size
organoids
patients.
In
addition,
single-cell
RNA
sequencing
identified
cell
type
abundance
distribution
organoids,
including
a
reduction
number
deep
layer
cortical
neurons
neural
progenitors.
Further,
cellular
analyses
patch-clamp
electrophysiology
detected
various
synapse
function.
Intriguingly,
C9-HRE
carriers
displayed
pathology,
whereas
extent
to
which
more
downstream
defects,
as
found
models,
were
varied
for
different
cases.
Together,
results
unveil
3D
human
tissue
organization
synaptic
that
likely
constitute
initial
crucial
understanding
onset
design
therapeutic
strategies.
Glia,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 25, 2024
Abstract
Substantial
advances
in
technology
are
permitting
a
high
resolution
understanding
of
the
salience
glia,
and
have
helped
us
to
transcend
decades
predominantly
neuron‐centric
research.
In
particular,
recent
‘omic’
technologies
enabled
unique
insights
into
glial
biology,
shedding
light
on
cellular
molecular
aspects
neurodegenerative
diseases,
including
amyotrophic
lateral
sclerosis
(ALS).
Here,
we
review
studies
using
omic
techniques
attempt
understand
role
glia
ALS
across
different
model
systems
post
mortem
tissue.
We
also
address
caveats
that
should
be
considered
when
interpreting
such
studies,
how
some
these
may
mitigated
through
either
multi‐omic
approach
and/or
careful
low
throughput,
fidelity
orthogonal
validation
with
particular
emphasis
functional
validation.
Finally,
consider
emerging
their
potential
relevance
deepening
our
ALS.